McGill University Health Centre at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

McGill University Health Centre brings 2 presentations to ISLB 2026 in Madrid. Its work centres on circulating tumour DNA for residual disease and early diagnosis. One study uses tumour DNA tracked over time to define residual disease and inform the MONITOR de-escalation trial, and another tests tumour DNA in blood as an extra diagnostic aid for thyroid nodules.

OrganizationISLB 2026 Attendance
Hospitals & cancer centres
Academic health network of McGill University's teaching hospitals in Montreal, with its own research institute.
Poster
Evaluating Liquid Biopsy for Circulating Tumor DNA Detection as a Complementary Diagnostic Tool in Thyroid Nodules
Early detection · ctDNA & MRD
Collaborators: McGill University

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from McGill University Health Centre

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction